12 July 2017
The procedure for compulsory licensing of drugs may be introduced in Russia as early as this year, said Igor Artemyev, the Head of the Federal Antimonopoly Service.
The compulsory licensing of drugs may be used in cases of epidemics or in situations where a company is the sole owner of a drug for a serious disease. In this case, the developer will receive compensation, while other pharmaceutical companies will be allowed to manufacture similar drugs (generics) without violating intellectual property rights.
“We will use (compulsory licensing). The USA used this procedure thousands of times and did it unceremoniously no matter who they were dealing with. But it seems that we are too tactful and therefore still cannot adopt this law. There is a decision of leadership, and this law will be adopted. I think that it will happen as early as this year,” said Mr. Artemyev.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024
Researchers propose novel test for pyrogen detection
27 March 2024
Parkinson’s infusion treatment demonstrates advantage over oral delivery
27 March 2024